Work

Abstract A015: Characterization of pharmacogenomic biomarkers in FDA oncology/hematology drug labelling: A descriptive regulatory review

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a015

Authors: Alhanouf Y. Alnafisah, Tariq H. Alqurayshah

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444679

Cites:

Cited by:

Related to: